Roche, AC Immune drop Alzheimer drug trials after setback

Roche Holding and partner AC Immune SA called a halt to two late-stage clinical trials of their crenezumab drug for early Alzheimer's, the latest in a string of failures to find a treatment for the progressive brain disease.

from Reuters: Health https://reut.rs/2FXG0vx
via IFTTT

• Tweet
• Share
• Share
• Share
• Share